The Potential of Combination Therapy in Combating Scarring Pathways
The realization that fibrotic diseases are driven by multiple, overlapping pathological pathways suggests that a single anti-fibrotic drug may not be sufficient for optimal long-term control. This has led to a growing scientific interest in combination therapy, using two or more agents that target different aspects of the fibrotic cascade. The hypothesis is that by simultaneously blocking...
0 Comments 0 Shares 267 Views 0 Reviews
Sponsored

🤑 Turn Clicks into Cash

Passive income unlocked! Share your link, bring users, and get paid every month. Adsterra makes it simple 💰